
Nuo Therapeutics: Biotech firm innovating regenerative therapies for wound care and inflammation.
Nuo Therapeutics, founded with the mission to innovate regenerative biological therapies, focuses on wound care, inflammation, and angiogenesis. As a commercial-stage medical device company, Nuo Therapeutics aims to offer more effective and efficient healing solutions by leveraging emerging opportunities in the healthcare sector. Their core products and services are designed to provide biologically relevant clinical solutions that improve patient health outcomes.
Notable figures associated with Nuo Therapeutics include leaders in biotechnology and healthcare innovation. The company has achieved significant milestones in developing and commercializing advanced biodynamic therapies. Their impact is evident in the improved treatment options available for patients suffering from chronic wounds and inflammatory conditions, positioning Nuo Therapeutics as a key player in the regenerative medicine landscape.

Nuon Therapeutics

Noveome Biotherapeutics
noveome.com

Novoron Bioscience
novoron.com

Nuvig Therapeutics

Nuveta
nuveta.com

NuOrtho Surgical

Noxsano
noxsano.com

Juventas Therapeutics
juventasinc.com

NovoThelium
novothelium.com

NeuroTherapeutics Pharma

Endonovo Therapeutics
endonovo.com

Nora Therapeutics

RegeneRx Biopharmaceuticals

BioNova
bionovamedical.com

Biofisica
biofisica.com
Companies similar to Nuo Therapeutics include Nuon Therapeutics, Noveome Biotherapeutics, Novoron Bioscience and Nuvig Therapeutics.
Nuo Therapeutics was founded in 1998.
Nuo Therapeutics' headquarters is located in Gaithersburg, MD, US.
Nuo Therapeutics' most recent funding round was for $962.5k (USD) in December 2023.
As of Dec 22, 2023, Nuo Therapeutics has raised a total of $118.3M (USD).
Nuo Therapeutics has 7 employees as of Feb 5, 2024.